Shingles in Seniors

Shingles typically begins with a prodrome of burning, tingling, or itching on one side of the body — 1 to 5 days before any rash appears. This is the stage most commonly missed because it can feel like a pulled muscle, skin irritation, or a bug bite. The key distinguishing features: the sensation is strictly one-sided (never crosses the body's midline), it follows the path of a nerve root (often wrapping around the torso like a belt, or appearing on one side of the face), and the skin in that area becomes hypersensitive — even light touch is painful. When the rash does appear, it consists of red patches that rapidly develop fluid-filled blisters over 24–48 hours, again strictly on one side of the body. If you are over 50 and experience unexplained one-sided burning pain or tingling — even without a rash — call your physician immediately. Antiviral treatment started during the prodrome (before the rash appears) is significantly more effective than treatment started after the rash develops. Never wait to see if a rash develops before seeking care.

Antiviral medications (valacyclovir, famciclovir, or acyclovir) dramatically reduce the severity, duration, and risk of complications — particularly postherpetic neuralgia (PHN) — when started within 72 hours of rash onset. Studies show antivirals reduce PHN incidence by 50–67% when started promptly. After 72 hours from rash onset, the benefit for uncomplicated shingles diminishes significantly because the viral replication that drives the acute infection has largely peaked. However, antivirals are still recommended after 72 hours for: seniors with moderate-to-severe pain, patients still developing new blisters (active viral replication), any patient with eye involvement (HZO) regardless of timing, immunocompromised patients, and patients with disseminated shingles. The practical implication: if you suspect shingles — even during the prodrome before any rash — call your physician immediately for an urgent appointment. Do not wait over the weekend for a Monday appointment. Do not wait for the rash to develop fully. The 72-hour window starts when the rash first appears, which means every hour of delay reduces the available treatment window.

The CDC and ACIP recommend Shingrix (recombinant zoster vaccine, RZV) for all adults aged 50 and older, regardless of prior history of shingles or the older Zostavax vaccination. Shingrix is given as two doses — the second dose is administered 2 to 6 months after the first. Its efficacy is 97% in adults 50–69 and 91% in adults 70 and older, making it one of the most effective vaccines available for adults. Key groups who especially need Shingrix: adults 50+ who have already had shingles (vaccination reduces recurrence risk), adults who received the older Zostavax vaccine (Shingrix is significantly more effective), immunocompromised adults 19 and older including those with diabetes, chronic steroid use, rheumatologic conditions on biologics, cancer treatment (ask your oncologist about timing), and HIV. Shingrix is a recombinant vaccine — it does not contain live virus and cannot cause shingles or chickenpox. Side effects are common and expected: arm soreness, fatigue, headache, and chills (reflecting an active immune response) — these typically resolve within 2–3 days. Having these side effects means your immune system is responding. Medicare Part D covers Shingrix — cost varies by plan formulary, ranging from $0 to approximately $50–$200 per dose.

Postherpetic neuralgia (PHN) is nerve pain that persists for 90 days or longer after the shingles rash has healed. It occurs because the herpes zoster virus damages the nerve fibers during the acute infection, leaving behind abnormal pain signaling that can continue for months or years. PHN affects 10–18% of shingles patients over 60 and up to 30% of adults over 80 — the risk increases substantially with age. PHN pain is often described as constant burning or aching combined with episodic electric-shock attacks, and the affected skin becomes hypersensitive to touch (allodynia — even clothing or a gentle breeze causes intense pain). PHN has severe quality-of-life consequences: it causes profound sleep disruption, depression, social withdrawal, reduced appetite, and functional decline — studies show PHN has a greater negative impact on quality of life than many cancers. Duration varies widely: some cases resolve within 3–6 months; others persist for years. Without active treatment, PHN in seniors rarely resolves spontaneously. Treatment with duloxetine, gabapentin, lidocaine patch 5%, or capsaicin 8% patch can provide substantial pain relief. The most effective prevention strategy for PHN is Shingrix vaccination (91% effective at preventing PHN in adults 70+) and prompt antiviral treatment within 72 hours of rash onset (reduces PHN incidence by 50–67%).

Shingles itself is not contagious — you cannot catch shingles from someone who has it. However, the fluid from shingles blisters contains active varicella-zoster virus and can cause chickenpox (not shingles) in people who have never had chickenpox and are not vaccinated against it. A person with shingles is contagious from when the blisters are oozing until all blisters have fully crusted over — typically 7–10 days. During this period, the rash should be covered and the person should avoid contact with: anyone who has never had chickenpox or the chickenpox vaccine, pregnant women (chickenpox during pregnancy can cause serious fetal complications), newborns (can cause severe neonatal disease), and immunocompromised individuals (cancer patients on chemotherapy, organ transplant recipients, people on immunosuppressive medications, those with HIV). People who have had chickenpox or received the varicella vaccine are protected against getting chickenpox from a shingles contact. Someone exposed to shingles blisters can develop chickenpox if susceptible — they cannot develop shingles directly from the contact. The varicella vaccine given within 3–5 days of exposure can prevent or reduce chickenpox severity in exposed unvaccinated people.

Yes — Medicare covers Shingrix, but the coverage path is Part D (prescription drug coverage), not Part B. This is a critical distinction because many seniors assume vaccines are covered under Part B (like flu shots, pneumonia vaccines, and COVID-19 vaccines, which are all covered under Part B with no cost-sharing). To get Shingrix covered by Medicare: use a pharmacy that participates in Medicare Part D and bill your Part D plan. The out-of-pocket cost depends on your specific Part D plan's formulary — Shingrix may be $0, or it may require a copay or coinsurance, sometimes $50–$200 per dose (two doses total). If you are in the Medicare Part D coverage gap (formerly the donut hole), you pay 25% of the plan's cost for brand-name drugs. Some Extra Help (Low Income Subsidy) beneficiaries have lower cost-sharing. Starting in 2023 under the Inflation Reduction Act, cost-sharing for Part D vaccines was capped and eventually eliminated for ACIP-recommended vaccines for most Part D enrollees. If cost is a barrier, ask your pharmacist about the Shingrix Patient Assistance Program through GSK, or contact your State Health Insurance Assistance Program (SHIP) for free Medicare counseling.

Herpes zoster ophthalmicus (HZO) — shingles affecting the eye area — is an ophthalmological emergency. If you have shingles and develop any of the following, seek same-day emergency ophthalmology evaluation: any rash on the forehead or around the eye (even without eye symptoms yet), rash on the tip of the nose (Hutchinson's sign — indicates the nasociliary branch of the trigeminal nerve is involved, which supplies the eye), eye redness, eye pain, blurred vision, sensitivity to light, or double vision. HZO can cause corneal ulceration, uveitis, glaucoma, retinal necrosis, and permanent vision loss if not treated promptly. Treatment requires systemic antiviral therapy (valacyclovir at the standard dose), topical ophthalmic antiviral drops (trifluridine), and often topical or oral corticosteroids — the specific regimen is determined by the ophthalmologist based on which eye structures are involved. Do not delay to see your primary care physician first if the eye is involved — go directly to an ophthalmologist or ER. The window for vision-preserving treatment can be very short. HZO accounts for 10–25% of shingles cases — it is not rare.